RJA
SOLV icon

Raymond James & Associates’s Solventum SOLV Stock Holding History

Raymond James & Associates’s Portfolio SOLV Stock Details SOLV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$13.5M Sell
194,108
-127,118
-40% -$7.65M 0.01% 1047
2024
Q2 		$17M Buy
+321,226
New +$19.5M 0.01% 859

Other funds holding SOLV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TFM
Trian Fund Management New York $4.23B AUM 31.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Raymond James & Associates's SOLV Position: Q3 2024 in Review

Raymond James & Associates reduced its Solventum (SOLV) stake by 40% in Q3 2024, selling an estimated $7.65M and leaving 194,108 shares worth $13.5M. The position accounts for 0.01% of the portfolio, ranked #1047.

Raymond James & Associates first reported a position in SOLV in Q2 2024 and has held it in 2 quarters since. The position peaked at $17M in Q2 2024. 938 funds tracked by Wall St. Rank hold SOLV as of Q3 2024.

  • Raymond James & Associates held 194,108 shares of Solventum worth $13.5M as of Q3 2024.
  • Raymond James & Associates sold 127,118 Solventum shares in Q3 2024, an estimated $7.65M.
  • Solventum made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1047 holding.
  • Raymond James & Associates first reported a position in Solventum in Q2 2024 and has held it in 2 quarters since.
  • Raymond James & Associates's Solventum position peaked at $17M in Q2 2024.
  • 938 funds tracked by Wall St. Rank held Solventum as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.